Literature DB >> 15922898

Autologous blood donation.

Lawrence T Goodnough1.   

Abstract

Preoperative autologous blood donation has become accepted as a standard practice in elective surgery. Subsequent improvements in blood safety and evolving surgical techniques resulting in less blood loss have caused a national decline in preoperative autologous blood donation by approximately 50%. Nevertheless, the continuing emergence of new pathogens and the potential for severe blood inventory shortages continue to give preoperative autologous blood donation an important role in blood conservation strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922898     DOI: 10.1016/j.atc.2004.07.003

Source DB:  PubMed          Journal:  Anesthesiol Clin North Am        ISSN: 0889-8537


  5 in total

1.  10 Autologous Hemotherapy.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

3.  Mild volume acute normovolemic hemodilution is associated with lower intraoperative transfusion and postoperative pulmonary infection in patients undergoing cardiac surgery -- a retrospective, propensity matching study.

Authors:  Zhen-Feng Zhou; Xiu-Ping Jia; Kai Sun; Feng-Jiang Zhang; Li-Na Yu; Tian Xing; Min Yan
Journal:  BMC Anesthesiol       Date:  2017-01-26       Impact factor: 2.217

Review 4.  Transfusion risks and transfusion-related pro-inflammatory responses.

Authors:  George John Despotis; Lini Zhang; Douglas M Lublin
Journal:  Hematol Oncol Clin North Am       Date:  2007-02       Impact factor: 3.722

5.  Prospective study of preoperative autologous blood donation for patients with high risk of allogeneic blood transfusion in lumbar fusion surgery: a study protocol of a randomised controlled trial.

Authors:  Nanfang Xu; Youyu Zhang; Yun Tian; Baohua Li; Haiqin Qiao; Xiaoqing Zhang; Nan Yang; Wei Li; Chao Zhang; Weishi Li; Wei Fu
Journal:  BMJ Open       Date:  2022-02-15       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.